JPS6236502B2 - - Google Patents

Info

Publication number
JPS6236502B2
JPS6236502B2 JP55091341A JP9134180A JPS6236502B2 JP S6236502 B2 JPS6236502 B2 JP S6236502B2 JP 55091341 A JP55091341 A JP 55091341A JP 9134180 A JP9134180 A JP 9134180A JP S6236502 B2 JPS6236502 B2 JP S6236502B2
Authority
JP
Japan
Prior art keywords
plasminogen
plasmin
amount
aprotinin
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55091341A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5716824A (en
Inventor
Mitsuomi Oogaki
Ryozo Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GC Biopharma Corp
Original Assignee
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Korea filed Critical Green Cross Corp Korea
Priority to JP9134180A priority Critical patent/JPS5716824A/ja
Priority to GB8100338A priority patent/GB2068002B/en
Priority to US06/225,532 priority patent/US4361653A/en
Priority to CA000368750A priority patent/CA1158551A/en
Priority to FR8100964A priority patent/FR2474313A1/fr
Priority to CH370/81A priority patent/CH650273A5/de
Priority to DE3102217A priority patent/DE3102217C2/de
Priority to SE8100393A priority patent/SE459783B/sv
Publication of JPS5716824A publication Critical patent/JPS5716824A/ja
Publication of JPS6236502B2 publication Critical patent/JPS6236502B2/ja
Priority to SE8803798A priority patent/SE8803798L/xx
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
JP9134180A 1980-01-25 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof Granted JPS5716824A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP9134180A JPS5716824A (en) 1980-07-03 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof
GB8100338A GB2068002B (en) 1980-01-25 1981-01-07 Plasminogen preparation and their production
US06/225,532 US4361653A (en) 1980-07-03 1981-01-16 Plasminogen preparations
CA000368750A CA1158551A (en) 1980-07-03 1981-01-19 Plasminogen preparations
FR8100964A FR2474313A1 (fr) 1980-01-25 1981-01-20 Preparation de plasminogene et son procede de production
CH370/81A CH650273A5 (de) 1980-01-25 1981-01-21 Plasminogenpraeparat und verfahren zu seiner herstellung.
DE3102217A DE3102217C2 (de) 1980-01-25 1981-01-23 Plasminogenpräparat und Verfahren zu seiner Herstellung
SE8100393A SE459783B (sv) 1980-01-25 1981-01-23 Stabilt plasminogenpreparat
SE8803798A SE8803798L (sv) 1980-01-25 1988-10-24 Plasminogenpreparat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9134180A JPS5716824A (en) 1980-07-03 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof

Publications (2)

Publication Number Publication Date
JPS5716824A JPS5716824A (en) 1982-01-28
JPS6236502B2 true JPS6236502B2 (en]) 1987-08-07

Family

ID=14023711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9134180A Granted JPS5716824A (en) 1980-01-25 1980-07-03 Plasminogen pharmaceutical and stabilizing method thereof

Country Status (3)

Country Link
US (1) US4361653A (en])
JP (1) JPS5716824A (en])
CA (1) CA1158551A (en])

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997001631A1 (fr) * 1995-06-26 1997-01-16 Daiichi Pure Chemicals Co., Ltd. Solution stable de plasmine

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119157A1 (de) * 1981-05-14 1982-12-09 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von und danach hergestelltes plasminogen
US4711369A (en) * 1983-11-18 1987-12-08 Monarch Marking Systems, Inc. Tab dispensing and attaching apparatus
US4682721A (en) * 1983-11-18 1987-07-28 Monarch Marking Systems, Inc. Tag dispensing and attaching apparatus
US4610384A (en) * 1983-11-18 1986-09-09 Monarch Marking Systems, Inc. Tag dispensing and attaching apparatus
US4610385A (en) * 1983-11-18 1986-09-09 Monarch Marking Systems, Inc. Tag dispensing and attaching apparatus
US4634036A (en) * 1983-11-18 1987-01-06 Monarch Marking Systems, Inc. Tag dispensing and attaching apparatus
US4673120A (en) * 1984-09-25 1987-06-16 Monarch Marking Systems, Inc. Hand-held tag attacher, method of attaching tags and fasteners
US4681248A (en) * 1984-09-25 1987-07-21 Monarch Marking Systems, Inc. Tag dispensing and attaching method and apparatus
US4706362A (en) * 1984-09-25 1987-11-17 Monarch Marking Systems, Inc. Method of attaching tags
US4683635A (en) * 1984-09-25 1987-08-04 Monarch Marking Systems, Inc. Tag dispensing and attaching method and apparatus
US4671442A (en) * 1984-09-25 1987-06-09 Monarch Marking Systems, Inc. Tag dispensing and attaching method and apparatus
US4696422A (en) * 1984-09-25 1987-09-29 Monarch Marking Systems, Inc. Hand-held tag attacher, method of attaching tags and fasteners
US4715521A (en) * 1984-09-25 1987-12-29 Monarch Marking Systems, Inc. Hand-held tag attacher
JPH0725696B2 (ja) * 1986-05-29 1995-03-22 株式会社ミドリ十字 プラスミノ−ゲンの安定化方法
GB2213285B (en) * 1987-12-29 1992-10-14 Asahi Optical Co Ltd Compact zoom lens system capable of high zoom ratio and having coverage of a wide visual field
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) * 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
BRPI0514435B8 (pt) 2004-08-20 2021-05-25 American Nat Red Cross isolamento sequêncial de proteínas e esquemas de purificação através de cromatografia por afinidade
JP2011522538A (ja) * 2008-06-04 2011-08-04 タレクリス・バイオセラピユーテイクス・インコーポレーテツド プラスミン製造のための組成物、方法およびキット
HUE025670T2 (en) 2009-03-03 2016-04-28 Grifols Therapeutics Inc A method for producing plasminogen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3066079A (en) * 1959-09-18 1962-11-27 American Cyanamid Co Methods for purifying plasminogen
US3227626A (en) * 1961-09-18 1966-01-04 Merck & Co Inc Plasminogen heat sterilization
NL133201C (en]) * 1964-04-28
US3732146A (en) * 1970-12-22 1973-05-08 Behringwerke Ag Process for the isolation of native, highly purified plasminogen
US3808124A (en) * 1972-04-14 1974-04-30 American Cyanamid Co Purification of human plasminogen
US3865692A (en) * 1974-01-11 1975-02-11 Abbott Lab Method for making highly potent plasminogen
FR2347048A2 (fr) * 1976-04-07 1977-11-04 Choay Sa Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997001631A1 (fr) * 1995-06-26 1997-01-16 Daiichi Pure Chemicals Co., Ltd. Solution stable de plasmine

Also Published As

Publication number Publication date
CA1158551A (en) 1983-12-13
US4361653A (en) 1982-11-30
JPS5716824A (en) 1982-01-28

Similar Documents

Publication Publication Date Title
JPS6236502B2 (en])
Lijnen et al. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein.
Sgouris et al. The preparation of human fibrinolysin (plasmin)
Credo et al. Ca2+-related regulatory function of fibrinogen.
Chibber et al. [48] Plasminogen
JPH07503454A (ja) プラズミンによる線維素溶解および線維素原溶解治療
EP0041173B2 (en) Blood-coagulation-promoting products and methods of preparing them
AU785103B2 (en) Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme
CA2285935C (en) An immunotolerant prothrombin complex preparation
US4379085A (en) Heat stabilization of plasma proteins
Thorsen et al. Reversible and Irreversible Alterations of Human Plasminogen Indicated by Changes in Susceptibility to Plasminogen Activators and in Response to∈-Aminocaproic Acid
US4082612A (en) Plasminogen activator complex
Sakata et al. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency
JPH01250399A (ja) トリグラミン、血小板凝集抑制性ポリペプチド
RU2142806C1 (ru) Способ очистки и хранения фактора ix, водный раствор очищенного фактора ix, композиция, содержащая фактор ix, способ лечения
Balldin et al. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis
JPS6235756B2 (en])
Wuepper et al. Plasma kinin system: proenzyme components
KR100296395B1 (ko) 단백질 c 또는 활성화 단백질 c 를 안정화시키는방법및안정화된조성물
Nissen et al. Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease
EP0099126B1 (en) Thrombolytic composition
JPH06217773A (ja) フィブリン親和性ウロキナーゼ複合体とその製法
Brinkhous et al. Thrombolysis and thrombolytic agents: a brief review
JPH0424331B2 (en])
Kopitar Isolation and some characteristics of urokinase inhibitors isolated from pig leucocytes